These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 23040140)

  • 21. Bleeding pattern and user satisfaction in second consecutive levonorgestrel-releasing intrauterine system users: results of a prospective 5-year study.
    Heikinheimo O; Inki P; Schmelter T; Gemzell-Danielsson K
    Hum Reprod; 2014 Jun; 29(6):1182-8. PubMed ID: 24682613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of action of the levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding.
    Cihangir U; Ebru A; Murat E; Levent Y
    Int J Gynaecol Obstet; 2013 Nov; 123(2):146-9. PubMed ID: 24028852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effectiveness of the levonorgestrel intrauterine system in obese women with heavy menstrual bleeding.
    Shaw V; Vandal AC; Coomarasamy C; Ekeroma AJ
    Aust N Z J Obstet Gynaecol; 2016 Dec; 56(6):619-623. PubMed ID: 27696346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cost-effectiveness of the levonorgestrel-releasing intrauterine system for the treatment of idiopathic heavy menstrual bleeding in the United States.
    Ganz ML; Shah D; Gidwani R; Filonenko A; Su W; Pocoski J; Law A
    Value Health; 2013; 16(2):325-33. PubMed ID: 23538185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized prospective trial comparing the levonorgestrel-releasing intrauterine system with thermal balloon ablation for the treatment of heavy menstrual bleeding.
    de Souza SS; Camargos AF; de Rezende CP; Pereira FA; Araújo CA; Silva Filho AL
    Contraception; 2010 Mar; 81(3):226-31. PubMed ID: 20159179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two Years Follow-Up of Patients with Abnormal Uterine Bleeding after Insertion of the Levonorgestrel-Releasing Intrauterine System.
    Cim N; Soysal S; Sayan S; Yildizhan B; Karaman E; Cetin O; Tolunay HE; Yildizhan R
    Gynecol Obstet Invest; 2018; 83(6):569-575. PubMed ID: 29223999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levonorgestrel-releasing intrauterine system versus laparoscopic supracervical hysterectomy for the treatment of heavy menstrual bleeding: a randomized study.
    Sesti F; Piancatelli R; Pietropolli A; Ruggeri V; Piccione E
    J Womens Health (Larchmt); 2012 Aug; 21(8):851-7. PubMed ID: 22519705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding.
    Busfield RA; Farquhar CM; Sowter MC; Lethaby A; Sprecher M; Yu Y; Sadler LC; Brown P; Johnson N
    BJOG; 2006 Mar; 113(3):257-63. PubMed ID: 16487195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts.
    Reid PC; Virtanen-Kari S
    BJOG; 2005 Aug; 112(8):1121-5. PubMed ID: 16045528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of a levonorgestrel 52-mg intrauterine system in the control of abnormal uterine bleeding in women with inherited bleeding disorders.
    Campos RR; Baêta T; Silva-Filho A; Rezende SM; Rocha ALL
    Contraception; 2020 Oct; 102(4):254-258. PubMed ID: 32470465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The levonorgestrel-releasing intrauterine system provides a reliable, long-term treatment option for women with idiopathic menorrhagia.
    Endrikat J; Vilos G; Muysers C; Fortier M; Solomayer E; Lukkari-Lax E
    Arch Gynecol Obstet; 2012 Jan; 285(1):117-21. PubMed ID: 21475963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endometrial ablation plus levonorgestrel releasing intrauterine system versus endometrial ablation alone in women with heavy menstrual bleeding: study protocol of a multicentre randomised controlled trial; MIRA2 trial.
    Oderkerk TJ; Beelen P; Geomini PMAJ; Herman MC; Leemans JC; Duijnhoven RG; Bosmans JE; Pannekoek JN; Clark TJ; Mol BWJ; Bongers MY
    BMC Womens Health; 2022 Jun; 22(1):257. PubMed ID: 35761328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of levonorgestrel and copper releasing intrauterine contraceptive device on body iron stores and menstrual bleeding patterns: experience on Indian women.
    Rana M; Saxena P; Firdous N
    Eur Rev Med Pharmacol Sci; 2012 Feb; 16(2):230-4. PubMed ID: 22428475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levonorgestrel-releasing intrauterine system for the management of heavy menstrual bleeding in women with inherited bleeding disorders: long-term follow-up.
    Chi C; Huq FY; Kadir RA
    Contraception; 2011 Mar; 83(3):242-7. PubMed ID: 21310286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bleeding pattern and safety of consecutive use of the levonorgestrel-releasing intrauterine system (LNG-IUS)--a multicentre prospective study.
    Gemzell-Danielsson K; Inki P; Boubli L; O'Flynn M; Kunz M; Heikinheimo O
    Hum Reprod; 2010 Feb; 25(2):354-9. PubMed ID: 19955104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of the levonorgestrel-releasing intrauterine system, quality of life and sexuality. Experience in an Italian family planning center.
    Bastianelli C; Farris M; Benagiano G
    Contraception; 2011 Oct; 84(4):402-8. PubMed ID: 21920196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The levonorgestrel intrauterine system (Mirena) for treatment of idiopathic menorrhagia. Assessment of quality of life and satisfaction.
    Lete I; Obispo C; Izaguirre F; Orte T; Rivero B; Cornellana MJ; Bermejo I;
    Eur J Contracept Reprod Health Care; 2008 Sep; 13(3):231-7. PubMed ID: 18609346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Femilis LNG-IUS: contraceptive performance-an interim analysis.
    Wildemeersch D; Janssens D; Andrade A
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders.
    Lukes AS; Reardon B; Arepally G
    Fertil Steril; 2008 Sep; 90(3):673-7. PubMed ID: 18001734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive factors for failure of the levonorgestrel releasing intrauterine system in women with heavy menstrual bleeding.
    Beelen P; van den Brink MJ; Herman MC; Geomini PM; Duijnhoven RG; Bongers MY
    BMC Womens Health; 2021 Feb; 21(1):57. PubMed ID: 33563257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.